SCHEMBL20504237

SCHEMBL20504237

CC(C#N)OC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27842797 1.00
SCHEMBL979980 0.79 TSHR (0.35)
SCHEMBL4047835 0.78 LMNA (0.39)
SCHEMBL5527894 0.78 LMNA (0.39)
SCHEMBL11104367 0.78 TDP1 (0.33)
SCHEMBL1235848 0.77
SCHEMBL20836416 0.77
SCHEMBL9427661 0.77
SCHEMBL17224246 0.77
SCHEMBL9194202 0.76 LMNA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840057-B2 Metal organic framework modifications of structural fibers EMBRY-RIDDLE AERONAUTICAL UNIVERSITY, INC. (US) 2023-12-12 US claimed
US-20220388277-A1 METAL ORGANIC FRAMEWORK MODIFICATIONS OF STRUCTURAL FIBERS EMBRY-RIDDLE AERONAUTICAL UNIVERSITY, INC. 2022-12-08 US claimed
US-20250248573-A1 Evacuation Dock With Fluid Management IROBOT CORPORATION 2025-08-07 US disclosed
US-12274412-B2 Evacuation dock with fluid management IROBOT CORPORATION (US) 2025-04-15 US disclosed
US-12193646-B2 Chimney and flange design for camera module MOBILEYE VISION TECHNOLOGIES LTD. (IL) 2025-01-14 US disclosed
CN-110475784-B Orthogonal protecting groups for preparing stereotactic phosphorothioate oligonucleotides 罗氏创新中心哥本哈根有限公司 2024-07-16 CN disclosed
US-12038672-B2 Systems and methods for flange focal length distribution MOBILEYE VISION TECHNOLOGIES LTD. (IL) 2024-07-16 US disclosed
CN-118290403-A Benzamide derivatives of pyrazolyl-amino-pyrimidinyl and compositions and methods thereof 凌科药业(杭州)有限公司 2024-07-05 CN disclosed
US-20240215781-A1 Evacuation Dock With Fluid Management IROBOT CORPORATION 2024-07-04 US disclosed
US-11930991-B2 Evacuation dock with fluid management IROBOT CORPORATION (US) 2024-03-19 US disclosed
US-11840057-B2 Metal organic framework modifications of structural fibers EMBRY-RIDDLE AERONAUTICAL UNIVERSITY, INC. (US) 2023-12-12 US disclosed
WO-2020099920-A1 SYSTEMS AND METHODS FOR FLANGE FOCAL LENGTH DISTRIBUTION MOBILEYE VISION TECHNOLOGIES LTD. (IL) 2020-05-22 WO disclosed
EP-3601309-A1 ORTHOGONAL PROTECTING GROUPS FOR THE PREPARATION OF STEREODEFINED PHOSPHOROTHIOATE OLIGONUCLEOTIDES Roche Innovation Center Copenhagen A/S (DK) 2020-02-05 EP disclosed
CN-110475784-A It is used to prepare the three-dimensional orthogonal protecting group for limiting phosphorothioate oligonucleotide ROCHE INNOVATION CT COPENHAGEN AS 2019-11-19 CN disclosed
WO-2018177825-A1 ORTHOGONAL PROTECTING GROUPS FOR THE PREPARATION OF STEREODEFINED PHOSPHOROTHIOATE OLIGONUCLEOTIDES ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2018-10-04 WO disclosed
EP-3377473-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX Pharmaceuticals, Inc. (US) 2018-09-26 EP disclosed
CN-102271682-B Be used for the treatment of the P2X of pain 3receptor antagonist MERCK SHARP & DOHME CORP. (US) 2015-12-16 CN disclosed
CN-102271682-A P2x3, receptor antagonists for treatment of pain 2011-12-07 CN disclosed
CN-100522161-C (indol-3-yl) -heterocyclic derivatives as agonists of the cannabinoid CB1 receptor AKZO NOBEL NV (NL) 2009-08-05 CN disclosed
CN-1929836-A (indol-3-yl) -heterocyclic derivatives as agonists of the cannabinoid CB1 receptor AKZO NOBEL NV (NL) 2007-03-14 CN disclosed